Andrew R. Hoffman, M.D.

NPI 1619924685ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Stanford, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Stanford, California, trained at Stanford University School of Medicine (class of 1976). Their prescriptions cost Medicare Part D more than their services did: $9,249 for 40 claims, against $3,183 paid for services in 2024. Ascendis Pharma Endocrinology Inc reported $9,355 in payments in 2025, mostly consulting fees.

Overview

NPI	1619924685
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	May 27, 2006
Last updated in NPPES	Apr 26, 2024
Certified by provider	Apr 26, 2024

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary	207RE0101X	G47300	CA
Internal Medicine	207R00000X	G47300	CA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Endocrinology (CA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	33
Services billed	44 across 9 procedure codes
Paid by Medicare	$3,183

Part D prescriptions in 2024

Prescriptions (claims)	40 · 87 30-day fills
Patients	12
Total drug cost	$9,249
Generic share	65% of claims

Medicare sources and data years

Education and affiliations

Medical school	Stanford University School of Medicine
Graduation year	1976
Medicare specialty	Endocrinology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth